Title : Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma.

Pub. Date : 2005 Dec

PMID : 16367911






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate ((90)Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma. ibritumomab tiuxetan membrane-spanning 4-domains, subfamily A, member 1 Mus musculus